BIA
TEVA icon

Bell Investment Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bell Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.61K Sell
136
-4
-3% -$133 ﹤0.01% 1013
2026
Q1 		$4.22K Sell
140
-116
-45% -$3.73K ﹤0.01% 1035
2025
Q4 		$7.99K Buy
256
+150
+142% +$3.69K ﹤0.01% 781
2025
Q3 		$2.14K Sell
106
-50
-32% -$878 ﹤0.01% 1309
2025
Q2 		$2.62K Hold
156
– – ﹤0.01% 1259
2025
Q1 		$2.4K Hold
156
– – ﹤0.01% 1240
2024
Q4 		$3.44K Hold
156
– – ﹤0.01% 1112
2024
Q3 		$2.81K Hold
156
– – ﹤0.01% 1213
2024
Q2 		$2.54K Sell
156
-38
-20% -$585 ﹤0.01% 1256
2024
Q1 		$2.74K Buy
194
+37
+24% +$466 ﹤0.01% 1213
2023
Q4 		$1.64K Buy
157
+25
+19% +$233 ﹤0.01% 1417
2023
Q3 		$1.35K Buy
+132
New +$1.23K ﹤0.01% 1458

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Bell Investment Advisors's TEVA Position: Q2 2026 in Review

Bell Investment Advisors reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 2.9% in Q2 2026, selling an estimated $133 and leaving 136 shares worth $4.61K. The position accounts for ﹤0.01% of the portfolio, ranked #1013.

Bell Investment Advisors first reported a position in TEVA in Q3 2023 and has held it in 12 quarters since. The position peaked at $7.99K in Q4 2025. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Bell Investment Advisors held 136 shares of Teva Pharmaceutical Industries Limited worth $4.61K as of Q2 2026.
  • Bell Investment Advisors sold 4 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $133.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1013 holding.
  • Bell Investment Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q3 2023 and has held it in 12 quarters since.
  • Bell Investment Advisors's Teva Pharmaceutical Industries Limited position peaked at $7.99K in Q4 2025.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.